ilShinBioBase Co Stock

ilShinBioBase Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of ilShinBioBase Co (068330.KQ) as of Jul 27, 2026 is 14.33. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 28.91 — a change of -50.43% (lower).

EV/EBIT

14.33

YoY

-50.43%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of ilShinBioBase Co is 2026 14.33 . EV/EBIT (Enterprise Value to EBIT) of ilShinBioBase Co was 2025 28.91 . It decreases by -50.43% lower compared to the previous year.

The ilShinBioBase Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
25.12 base
Jan 1, 2019
17.34 base
Jan 1, 2020
67.42 base
Jan 1, 2021
24.61 base
Jan 1, 2022
12.91 base
Jan 1, 2023
9.29 base
Jan 1, 2024
19.61 base
Jan 1, 2025
15.13 base
YEARPRICE-TO-EBIT
2025 15.13
2024 19.61
2023 9.29
2022 12.91
2021 24.61
2020 67.42
2019 17.34
2018 25.12
2017 43.81
2016 37.72
2015 40.68
2014 15.41
2013 27.26
2012 12.72
2011 31.51
2010 17.98
2009 5.80
2008 8.59
2007 4.59
2006 -
Access this data via the Eulerpool API
Get Free API Key

ilShinBioBase Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides ilShinBioBase Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates ilShinBioBase Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots ilShinBioBase Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if ilShinBioBase Co grows earnings faster than its peers.

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

EV/EBIT (Enterprise Value to EBIT) of ilShinBioBase Co is 14.33 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — ilShinBioBase Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — ilShinBioBase Co